Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HIMX
3276
CALL
Himax Technologies
HIMX
$2.66B
| $6.34M | ﹤0.01% |
847,800
+352,200
| +71% | +$3.24M |
|
3277
QuantumScape Corp
QS
$3.81B
| $6.33M | ﹤0.01% |
736,937
+471,381
| +178% | +$6.29M |
|
|
CFLT
3278
PUT
DELISTED
Confluent
CFLT
| $6.32M | ﹤0.01% |
272,100
-165,400
| -38% | -$4.45M |
|
3279
Iridium Communications
IRDM
$5.32B
| $6.32M | ﹤0.01% |
168,335
-97,226
| -37% | -$3.63M |
|
3280
CALL
British American Tobacco
BTI
$123B
| $6.32M | ﹤0.01% |
147,300
-422,500
| -74% | -$18.1M |
|
3281
CALL
Blink Charging
BLNK
$85.9M
| $6.32M | ﹤0.01% |
382,300
-17,100
| -4% | -$321K |
|
3282
CALL
ProShares UltraPro Short S&P 500
SPXU
$380M
| $6.32M | ﹤0.01% |
15,619
-4,210
| -21% | -$1.45M |
|
3283
Worthington Enterprises
WOR
$2.87B
| $6.32M | ﹤0.01% |
232,373
+212,177
| +1,051% | +$6.15M |
|
|
SCLE
3284
DELISTED
Broadscale Acquisition Corp. Class A common stock
SCLE
| $6.32M | ﹤0.01% |
643,035
-2,227
| -0.3% | -$21.9K |
|
3285
Brighthouse Financial
BHF
$3.37B
| $6.31M | ﹤0.01% |
153,820
-25,083
| -14% | -$1.21M |
|
3286
Ericsson
ERIC
$33.6B
| $6.31M | ﹤0.01% |
852,636
+467,263
| +121% | +$3.82M |
|
3287
PUT
Sibanye-Stillwater
SBSW
$7.62B
| $6.31M | ﹤0.01% |
632,600
+324,100
| +105% | +$4.23M |
|
3288
CALL
Vanguard FTSE Emerging Markets ETF
VWO
$125B
| $6.31M | ﹤0.01% |
151,400
+79,300
| +110% | +$3.42M |
|
3289
PUT
Global E Online
GLBE
$7.12B
| $6.3M | ﹤0.01% |
312,500
+91,200
| +41% | +$2.09M |
|
|
FOUN
3290
DELISTED
Founder SPAC Class A Ordinary Shares
FOUN
| $6.3M | ﹤0.01% |
626,524
+1,523
| +0.2% | +$15.3K |
|
|
DTRT
3291
DELISTED
DTRT Health Acquisition Corp. Class A Common Stock
DTRT
| $6.3M | ﹤0.01% |
625,100
-972,411
| -61% | -$9.76M |
|
3292
MaxCyte
MXCT
$136M
| $6.3M | ﹤0.01% |
1,331,342
-165,418
| -11% | -$815K |
|
3293
CALL
iShares MSCI South Korea ETF
EWY
$27.8B
| $6.3M | ﹤0.01% |
108,200
-983,000
| -90% | -$64.3M |
|
|
B
3294
DELISTED
Barnes Group Inc.
B
| $6.29M | ﹤0.01% |
201,972
+70,992
| +54% | +$2.47M |
|
3295
CALL
First Horizon
FHN
$12.4B
| $6.29M | ﹤0.01% |
287,600
-118,900
| -29% | -$2.67M |
|
3296
CALL
iShares US Transportation ETF
IYT
$2.28B
| $6.28M | ﹤0.01% |
118,000
-283,600
| -71% | -$16.5M |
|
3297
CALL
Vanguard Morningstar Small-Cap Value ETF
VBR
$38.3B
| $6.28M | ﹤0.01% |
41,900
+26,400
| +170% | +$4.33M |
|
3298
PUT
Willis Towers Watson
WTW
$30.8B
| $6.28M | ﹤0.01% |
31,800
+12,400
| +64% | +$2.66M |
|
|
NNDM
3299
Nano Dimension
NNDM
$344M
| $6.28M | ﹤0.01% |
1,998,586
+1,149,218
| +135% | +$3.41M |
|
3300
CALL
Factset
FDS
$10.1B
| $6.27M | ﹤0.01% |
16,300
-15,800
| -49% | -$6.18M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.